The evaluation of other frequent prostatic diseases like benign hyperplasia, prostatitis, and follow-up studies for prostate cancer after radiotherapy or hormonal treatment may also be performed based on concile® PSA analysis. This evidence concerns the gene KLK3 and medical procedure.